Idglobal Corp.OTC: IDGC

IDGLOBAL and its Pharmaceutical Label Partner, ATL Pharma Security Label

· Issued by Idglobal Corp. via Business Wire
IDGLOBAL and its Pharmaceutical Label Partner, ATL Pharma Security Label Systems?, Jointly Exhibited to the National Association of Drug Diversion Investigators (NADDI) in Tampa KELOWNA, British Columbia December 4, 2007 -- (Business Wire) IDGLOBAL (Pink Sheets:IDGJ) is pleased to announce that IDGLOBAL and its pharmaceutical label partner, ATL Pharma Security Label Systems? (www.atlco.com), jointly exhibited to the National Association of Drug Diversion Investigators (NADDI) in Tampa at the NADDI annual meeting. IDGLOBAL and ATL were featured guest speakers to the pharmaceutical industry's top-level investigators. Discussion surrounded new innovations regarding brand protection including new technology and security protocols as they apply to the industry where counterfeited products are resulting in severe injuries / sickness and even death. The new IDGLOBAL Track and Trace? technology features proprietary embedding technology that combines its Nano-Molecular Markers? with real-time chain supply management utilizing mass serialization and client interface technologies, which is similar to its application as RFID technology. Follow this link for more information regarding IDGLOBAL's Track and Trace? and ATL Pharma Security Label Systems?: www.atlco.com/medical/Pharma.html. Phil Viggiani, VP Sales & Marketing for IDGLOBAL stated, "The NADDI show in Tampa represented the second major U.S. pharmaceutical conference IDGLOBAL and ATL have attended and resulted in a number of "one on one" meetings and several introductory stage discussions to further investigate and qualify IDGLOBAL's Track and Trace? product for a number of multi-national pharmaceutical companies." On July 24, 2007, IDGOBAL announced a ten year agreement to supply its Nano- Molecular Marking? anti-counterfeiting technology to the renowned pharmaceutical labeling corporation ATL Pharma Security Label Systems?, a division of Ad Tape & Label Co. Phil Viggiani continued, "ATL is arguably one of the most successful and accredited pharmaceutical "clinical studies" label manufacturer in North America and has exponentially enhanced our immediate sales opportunities in this highly lucrative market vertical. The NADDI trade show resulted in the IDGLOBAL team initiating multiple opportunities for follow-up presentations, including an extensive presentation meeting with one of the world's top five pharmaceutical manufacturers. The timing is exceptional considering IDGLOBAL expects to showcase its Track and Trace? technology to another 50+ Fortune 500 companies at its next trade show appearance, details of which will be announced shortly." About IDGLOBAL Corp. (www.idglobalcorp.com) IDGLOBAL provides a range of leading technologies specifically designed to provide private enterprise and governments 100% solutions to their Counterfeiting infections and Loss Prevention/Anti-Theft security programs. IDGLOBAL's Nano-Molecular Markers/Tags? are specifically designed for global anti-counterfeiting applications and its IDFORENSIX? products provide Loss Prevention/Anti-Theft solutions for the annual $800 billion Anti-Counterfeiting and Loss Prevention markets. IDGLOBAL is a forwardlooking company with a robust R&D program and product development and integration program for the purpose of providing next-generation Nano-based and leading-edge Anti-Counterfeiting products and Security solutions. Nano-Molecular, Nano-Molecular Markers, Nano-Molecular Tags, Track and Trace and IDFORENSIX are registered trademarks of IDGLOBAL Corp. All Rights Reserved. This press release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of IDGLOBAL Corp. to be materially different from the statements made herein. Contacts: IDGLOBAL Corp. Daryl Regier, CEO, President Philip Viggiani, VP, Sales Marketing Marc Hamilton, Chief Operating Officer Investor Relations, Toll Free: 1-866-922-4345 Phone: 250-862-8933 Fax: 250-862-8322 www.idglobalcorp.com Source: IDGLOBAL Corp.